Ratings Sabra Health Care REIT, Inc.

Equities

SBRA

US78573L1061

Market Closed - Nasdaq 04:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
13.43 USD -0.22% Intraday chart for Sabra Health Care REIT, Inc. -2.54% -5.89%

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • The company appears to be poorly valued given its net asset value.
  • This company will be of major interest to investors in search of a high dividend stock.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
  • The firm trades with high earnings multiples: 23.16 times its 2024 earnings per share.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialized REITs

1st Jan change Capi. Investor Rating ESG Refinitiv
-5.89% 3.11B
C+
+0.71% 53.67B
A-
-14.45% 17.17B
A-
-9.04% 12.78B
A
-2.22% 7.35B
B
-19.97% 5.26B
B-
+6.08% 3.2B
C-
-8.88% 2.93B
B+
+1.63% 3.02B
C
+8.22% 2.62B
C-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. SBRA Stock
  4. Ratings Sabra Health Care REIT, Inc.